Biopharma / Medtech Reports

June 17, 2026

Rx MFN: Sector Risk Inbound?

•

John Leppard
June 16, 2026

EW: TAVR Draft Coverage Puts & Takes

•

John Leppard

EW (US)
June 11, 2026

[EW, MDT, ABT] TAVR: Incremental Gains From Expected Coverage

•

John Leppard

ABT (US), EW (US), MDT (US)
June 10, 2026

GKOS iDose: MAC Pushback Persists

•

John Leppard

GKOS (US)
June 3, 2026

DXCM: What to Expect When You’re Expecting CGM Coverage

•

John Leppard

DXCM (US)
May 28, 2026

INSP: Noridian’s Modifier & Service Date Inconsistencies

•

John Leppard

INSP (US)
May 26, 2026

GKOS: iDose LCD & Laser Headwinds

•

John Leppard

GKOS (US), SGHT (US)
May 21, 2026

GKOS: iDose Coverage & Second Line Therapy

•

John Leppard

GKOS (US)
May 15, 2026

INSP: New Code Denial & Implications

•

John Leppard

INSP (US), LIVN (US), NYXH (US)
May 7, 2026

iRhythm (IRTC): Final LCD Signals Relief, Modest Headwind

•

John Leppard

IRTC (US)